key: cord-0313760-3n7s3lj5 authors: Chaw, L.; Lee, S. H.; Hazwani Jaafar, N. I.; Lim, E.; Sharbawi, R. title: Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study. date: 2021-04-01 journal: nan DOI: 10.1101/2021.03.30.21254670 sha: eb02b2e8223b20b61acdfcabd73c521da19ba939 doc_id: 313760 cord_uid: 3n7s3lj5 Objective: Uptake for cervical cancer screening remains well below the recommended rate of 80%. We conducted a pilot study to determine the reasons for non-attendance and explore their acceptance of human papillomavirus (HPV) self-sampling as an alternative to Pap test. Methods: A two-part cross-sectional study was conducted at a health centre in Brunei, from January to December 2019. Women who were eligible for a Pap test but who either never or did not have one within the past four years were conveniently recruited. Participants were first asked to complete a paper-based survey on their reasons for screening non-attendance, and then invited for HPV self-sampling. Results were analysed using descriptive and inferential statistics. Result: We enrolled 174 screening non-attendees, out of which 97 (55.7%) also participated in HPV self-sampling. The main reasons for not attending Pap test screening were fear of bad results (16.1%, n = 28); embarrassment (14.9%, n = 26) and lack of time due to home commitments (10.3%, n = 18). When compared to those who agreed to participate in HPV self-sampling, those who declined were significantly older (p = 0.002) and less likely to agree that they are susceptible to cervical cancer (p = 0.023). They preferred to receive Pap-test related information from healthcare workers (59.0%, n = 155), social messaging platforms (28.7%, n = 51) and social media (26.4%, n = 47). HPV self-sampling kits were positively-received, where > 90% agreed on its ease and convenience. Nine of 97 participants (9.3%) tested positive for hr-HPV, out of which eight were non-16/18 HPV genotypes. Conclusion: Our findings suggest that promoting knowledge on cervical cancer, the benefits of screening and clarifying any misconceptions of Pap test results would help increase screening uptake among Bruneian non-attendees. Response to HPV self-sampling was highly positive, implying its receptiveness in the local setting. Our high detection of non-16/18 HPV genotypes suggest high prevalence of other hr-HPV genotypes in Brunei. Larger studies can be conducted to further validate our findings. National Pap Test Registry, organising cervical screening through periodic mail invitations for translated to Brunei-Malay language by native speakers, and then back-translated to check for inconsistencies in comprehension. Both questionnaires were also pre-tested on six eligible women test; attitude and knowledge on cervical cancer; and lastly, preferred sources to acquire information 144 about Pap test. From a prepared list of 16 options, participants were asked to select one ("Major" 145 reason) or more reasons (categorized as "Minor" reasons) for not attending the screening 146 programme. Responses for questions on their attitude and knowledge on cervical cancer were 147 assessed using a five-point Likert scale, ranging from "Strongly Agree" to "Strongly Disagree". Q2 consists of 12 five-point Likert scale questions (ranging from "Strongly Agree" to "Strongly Disagree") 149 on their experiences and opinions of the self-sampling kit. Descriptive statistics was conducted to characterize the socio-demographic characteristics of the 176 study population, their reasons for not attending screening, their attitudes and preference for 177 information access on such screening, as well as responses from Q2. Mann-Whitney and Fisher's exact tests were used to assess significant differences in sociodemographic characteristics between 179 women who agreed and women declined to proceed to the HPV self-sampling part of the study. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 A total of 174 eligible women were enrolled into the study from January to December 2019, out of ranging between 23 and 65 years (Table 1) . The participants were mainly of Malay ethnicity (92.5%, the participants had their last Pap test performed between 4 and 10 years ago (52.3%, n = 91) and 193 have never received the HPV vaccine (54.6%, n = 95). There were significant differences between 194 those who agreed and declined to participate in HPV self-sampling: those who declined were 195 significantly older (p = 0.002) and more likely to have their last Pap test performed more than 10 196 years ago (p = 0.031). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 1, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10.1101/2021.03.30.21254670 doi: medRxiv preprint Figure 2 and Table S1 show the responses for the major and minor reasons for not attending cervical 206 cancer screening. The top three major reasons reported were that they were "afraid of getting a bad 207 result" (16.1%, n = 28), "feeling embarrassed being examined by a doctor or nurse" (14.9%, n = 26), 208 and "I can't find the time as I'm too busy at home" (10.3%, n = 18). The top three minor reasons 209 were "feeling embarrassed being examined by a doctor or nurse" (20.7%, n = 36), "I can't find time When comparing top 10 major reasons for not attending screening between those who agreed and 219 declined HPV self-sampling (Table 2) , those whose major reason was "feeling embarrassed being . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10.1101/2021.03.30.21254670 doi: medRxiv preprint those whose major reason was "afraid of getting a bad result" were significantly more likely to 222 decline self-sampling (p = 0.034). Among those who were employed (n = 98), about a quarter (23.5%, 223 n = 23) reported work-related reasons as their major reason for not attending screening ("I can't find 224 the time as I'm too busy at work" and "Difficult to get permission from employer"). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. (Jan -Dec 2019), with comparison between those who agreed and declined HPV self-sampling. Responses from 146 participants (83.9% of the total study population) were included. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. Responses from the total study population (n = 174) were included. Most participants responded that they would like to obtain more information about cervical cancer 251 screening (85.6%, n = 149). The top preferred information sources were healthcare workers (59.8%, 252 n = 104), social messaging platforms (28.7%, n = 50) and social media (26.4%, n = 46; Figure 3 ). 254 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. Healthcare worker . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. between those who tested hr-HPV positive and those who tested hr-negative (Table S2) . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. Lack of information or knowledge has been suggested to reduce women's concerns towards cervical 302 cancer [25] and whether to continue attending cervical screening [26] . Although fear, 303 embarrassment and other psychosocial barriers may play a large role at the onset of screening 304 programme, its role diminishes over time with increasing education and knowledge of screening 305 [27] . Educational interventions could also benefit the small group of women who cited menopause, 306 cessation of child-bearing and having had HPV vaccination as reasons for not attending screening. Promoting cervical cancer awareness could also impact non-attendees' decision to participate in 309 HPV self-sampling. In our study, we observed those who agree that they are susceptible to cervical 310 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 cancer were significantly more likely to participate in HPV self-sampling. This suggests that perceived 311 susceptibility could be an important factor for self-sampling participation, whereby those who do 312 not perceive themselves as susceptible were less likely to engage in preventative behaviours 313 [25, 28, 29] . Perceived susceptibility can be increased through education to improve their beliefs on 314 the necessity of screening [30] . We suggest that such information could be more effectively Second, we observed high acceptability of HPV self-sampling among our participants. Indeed, meta-320 analyses have indicated strong acceptance of self-sampling and a preference for the latter over 321 clinician sampling [32], mainly due to logistical reasons [33] . Implementing HPV self-sampling in 322 screening programmes have been shown to increase the screening uptake among non-attendees 323 [3, 4, 7] , and also increases the detection of CIN 2+ lesions [8, 9] . Providing HPV self-sampling as a 324 cervical cancer screening option could also encourage those, whose main reason for not attending 325 was fear of pain due to previous experience, to attend screening. This reason, also common in our 326 study, was reported as a factor for avoiding screening [34] and is suggested to predict future 327 screening uptake [35] . Among those who joined HPV self-sampling in our study, at least half cited 328 embarrassment, fear of pain or lack of time due to home and/or work commitments as their major 329 reason of not attending screening. This suggest that flexibility to accommodate women's screening 330 method preference [36] , such as the option to carry out self-sampling [37], could improve screening 331 uptake. Notably, only about three-quarters of our self-sampling participants were confident of the result 334 accuracy and less than two-thirds were willing to do the self-sampling at home, suggesting that 335 these participants could be doubting their technique and would prefer to do this in clinics instead. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10.1101/2021.03.30.21254670 doi: medRxiv preprint nine participants tested positive for HPV 16. Even though our sample size is small, this result 342 suggests that it may not be accurate to assume HPV 16 or 18 as common hr-HPV genotypes in 343 Brunei, although this is true in the global context [38] . Other studies have detected a significant 344 percentage of non-16/18 hr-HPV genotypes, suggesting the presence of region-specific 345 heterogeneity in the HPV genotype distribution [38] [39] [40] [41] [42] . Also, variation in HPV distribution among 346 different ethnic groups has been reported in an American study [43] , although reasons for these 347 differences are unclear. Our finding has potential implication on Brunei's national school-based HPV 348 vaccination programme which currently provides vaccines which do not confer protection against 349 non-16/18 genotypes. Providing vaccines that confers protection against nine hr-HPV genotypes [44] 350 could be a better alternative for Bruneian females. Larger population-based studies to understand 351 the distribution of HPV genotypes among Bruneian women will be crucial to determine the efficacy 352 or impact of the current vaccines. A major limitation for this study is that non-attendees from only one health center were recruited, CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 In conclusion, our findings indicate the need to further promote education and awareness towards 362 cervical cancer and its screening process. Reasons of cervical cancer screening non-attendance were 363 mainly related to emotional and logistical factors. As we found high acceptance towards HPV self-364 sampling, this could be adopted as an alternative for women who refrain from Pap test. Our high 365 detection of non-16/18 HPV genotypes suggest high prevalence of other hr-HPV genotypes in Brunei. Future larger studies involving more Bruneian women can be done to verify our results. Follow-up studies should also be done to consider HPV testing as the suitable method for cervical 368 cancer screening. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 review of high-risk HPVs and a plea to the CDC. Am J Stem Cells. 2019. 523 524 525 526 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10.1101/2021.03.30.21254670 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 1, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 1, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 1, 2021. ; https://doi.org/10. 1101 /2021 International incidence rates of invasive cervical 17 Experiences of cervical screening 35 Acceptability of self-collection 39 Prevalence and Genotype Distribution of 506 HPV Infection in China: Analysis of 51,345 HPV Genotyping Results from China's Largest CAP 507 Certified Laboratory Racial differences in 519 human papilloma virus types amongst United States women with HIV and cervical precancer The nonavalent vaccine: a $1000 The authors would like to thank the JPSHC staff who have assisted in participant recruitment and 372 questionnaire distribution.